![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, June 01, 2022 11:02:10 PM
Throw HCT into a phase 2. That’s good for a few years of milk. Pluristem and Tnuva could just keep silent for a few years too. Like UTHR or CHA deals. Won’t even mention the Japanese partner they should have by the end of 2016 as promised. Bring back some GvHD pre-clinical results and start a phase 1. Throw away some more cash and hire another SSCIENTIFIC steering committee on preeclampsia. Who cares if you have to pay them. Some will lap it up like good little minions.
But seriously I could see them getting to half a billion. Only another $150 mil to go. How they’ve made it to $350 mil so far is mind blowing. But raises are the ONLY thing this company does well. All to benefit employees ONLY unfortunately.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM